Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Richet

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|July 1, 1988
Comparative in vitro activities of pristinamycin, its components, and other antimicrobial agents against anaerobic bacteriaH Laforest, M Fourgeaud, H Richet, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 2, 2011
Diversity of Mycobacterium avium subsp. hominissuis mycobacteria causing lymphadenitis, FranceL Despierres, S Cohen-Bacrie, H Richet, et al.
FEMS Microbiology Letters|May 5, 1999
Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase productionN Caroff, E Espaze, I Bérard, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2000
Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing ampCN Caroff, E Espaze, D Gautreau, et al.
European Journal of Dermatology : EJD|November 10, 2001
Erythromycin-resistance of cutaneous bacterial flora in acneB Dreno, A Reynaud, D Moyse, et al.
The American Journal of Medicine|November 30, 1989
Comparative efficacy of ciprofloxacin versus josamycin in the treatment of acute, recurrent, or exacerbated bronchitisP Canton, B Hoen, H Richet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2000
Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal floraP Richard, M H Delangle, F Raffi, et al.
British Poultry Science|December 19, 2007
Growth-promoting effects of single-dose intragastrically administered probiotics in chickensM Khan, D Raoult, H Richet, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 30, 2002
Candidemia in French hospitals: incidence rates and characteristicsH Richet, P Roux, C Des Champs, et al.
Pathologie-Biologie|May 1, 1992
[In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections]A E Reynaud, E P Espaze, M Coste-Burel, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|July 1, 1988
Comparative in vitro activities of pristinamycin, its components, and other antimicrobial agents against anaerobic bacteriaH Laforest, M Fourgeaud, H Richet, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 2, 2011
Diversity of Mycobacterium avium subsp. hominissuis mycobacteria causing lymphadenitis, FranceL Despierres, S Cohen-Bacrie, H Richet, et al.
FEMS Microbiology Letters|May 5, 1999
Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase productionN Caroff, E Espaze, I Bérard, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2000
Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing ampCN Caroff, E Espaze, D Gautreau, et al.
European Journal of Dermatology : EJD|November 10, 2001
Erythromycin-resistance of cutaneous bacterial flora in acneB Dreno, A Reynaud, D Moyse, et al.
The American Journal of Medicine|November 30, 1989
Comparative efficacy of ciprofloxacin versus josamycin in the treatment of acute, recurrent, or exacerbated bronchitisP Canton, B Hoen, H Richet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2000
Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal floraP Richard, M H Delangle, F Raffi, et al.
British Poultry Science|December 19, 2007
Growth-promoting effects of single-dose intragastrically administered probiotics in chickensM Khan, D Raoult, H Richet, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 30, 2002
Candidemia in French hospitals: incidence rates and characteristicsH Richet, P Roux, C Des Champs, et al.
Pathologie-Biologie|May 1, 1992
[In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections]A E Reynaud, E P Espaze, M Coste-Burel, et al.
Pageof 8